The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Conditions: Endometrial Polyp; Endometrial Diseases Interventions: Drug: Drospirenone / Estetrol; Drug: Nomegestrol Acetate / Estradiol; Drug: Ethinylestradiol / Dienogest Sponsors: University of Palermo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib
Conditions: Healthy Volunteers Interventions: Drug: Obicetrapib; Drug: Obicetrapib + Drospirenone / Ethinyl Estradiol (COC); Drug: Drospirenone / Ethinyl Estradiol (COC) Sponsors: NewAmsterdam Pharma; Novum Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Evaluate the Impact of Pharmacokinetics of Drospirenone and Ethinyl Estradiol in Female Subjects Taking Obicetrapib.
Conditions: Healthy Volunteers Interventions: Drug: Obicetrapib; Drug: Obicetrapib + Drospirenone / Estradiol; Drug: Drospirenone / Estradiol Sponsors: NewAmsterdam Pharma; Novum Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz ®
Conditions: Healthy Subjects Interventions: Drug: Drospirenone+ Ethinyl Estradiol Tablets-Test product; Drug: Drospirenone+ Ethinyl Estradiol Tablets-Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin ®
Conditions: Healthy Subjects Interventions: Drug: Drospirenone+ Ethinyl Estradiol Tablets-Test product; Drug: Drospirenone+ Ethinyl Estradiol Tablets-Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Condition: Overweight Interventions: Drug: LY3437943; Drug: Ethinyl Estradiol; Drug: Drospirenone Sponsor: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
